AU2003240225A1 - Injectable bisphosphonate formulations - Google Patents

Injectable bisphosphonate formulations

Info

Publication number: AU2003240225A1
Authority: AU; Australia
Prior art keywords: injectable; bisphosphonate formulations; bisphosphonate; formulations; injectable bisphosphonate
Prior art date: 2002-05-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003240225A

Inventor

Andrea Capocchi

Rossella Musa

Annamaria Soliani Raschini

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Chiesi Farmaceutici SpA

Original Assignee

Chiesi Farmaceutici SpA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-13

Filing date

2003-05-12

Publication date

2003-11-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27639074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2003240225(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-05-12 Application filed by Chiesi Farmaceutici SpA filed Critical Chiesi Farmaceutici SpA

2003-11-11 Publication of AU2003240225A1 publication Critical patent/AU2003240225A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Orthopedic Medicine & Surgery (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AU2003240225A 2002-05-13 2003-05-12 Injectable bisphosphonate formulations Abandoned AU2003240225A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
ITTO2002A000406		2002-05-13
IT2002TO000406A ITTO20020406A1 (en)	2002-05-13	2002-05-13	FORMULATIONS OF BISPHOSPHONATES FOR INJECTABLE USE.
PCT/EP2003/004934 WO2003094925A1 (en)	2002-05-13	2003-05-12	Injectable bisphosphonate formulations

Publications (1)

Publication Number	Publication Date
AU2003240225A1 true AU2003240225A1 (en)	2003-11-11

Family

ID=27639074

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003240225A Abandoned AU2003240225A1 (en)	2002-05-13	2003-05-12	Injectable bisphosphonate formulations

Country Status (5)

Country	Link
AR (1)	AR040001A1 (en)
AU (1)	AU2003240225A1 (en)
IT (1)	ITTO20020406A1 (en)
PE (1)	PE20040193A1 (en)
WO (1)	WO2003094925A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006012700A1 (en) *	2004-08-04	2006-02-09	Team Health Pty Ltd	Method of treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1187828B (en) *	1985-05-24	1987-12-23	Gentili Ist Spa	PHARMACEUTICAL COMPOSITION BASED ON DIPHOSPHONATES FOR THE TREATMENT OF ARETROSIS
US5462932A (en) *	1994-05-17	1995-10-31	Merck & Co., Inc.	Oral liquid alendronate formulations
IT1296495B1 (en) *	1997-11-21	1999-06-25	Prodotti Antibiotici Spa	USE OF BISPHOSPHONATES IN THE PREPARATION OF PHARMACEUTICAL FORMS FOR INTRAMUSCULAR ADMINISTRATION
US6677320B2 (en) *	2000-01-20	2004-01-13	Hoffmann-La Roches Inc.	Parenteral bisphosphonate composition with improved local tolerance
EP1136069A1 (en) *	2000-03-21	2001-09-26	SPA SOCIETA' PRODOTTI ANTIBIOTICI S.p.A.	Pharmaceutical compositions containing clodronates for high local tolerance intramuscular administration

2002
- 2002-05-13 IT IT2002TO000406A patent/ITTO20020406A1/en unknown
2003
- 2003-05-06 PE PE2003000440A patent/PE20040193A1/en not_active Application Discontinuation
- 2003-05-12 WO PCT/EP2003/004934 patent/WO2003094925A1/en not_active Ceased
- 2003-05-12 AU AU2003240225A patent/AU2003240225A1/en not_active Abandoned
- 2003-05-12 AR ARP030101639A patent/AR040001A1/en unknown

Also Published As

Publication number	Publication date
PE20040193A1 (en)	2004-05-31
WO2003094925A1 (en)	2003-11-20
AR040001A1 (en)	2005-03-09
ITTO20020406A1 (en)	2003-11-13
ITTO20020406A0 (en)	2002-05-13

Publication	Publication Date	Title
AU2003239690A1 (en)	2003-12-12	Jettable compositions
AU2003266949A1 (en)	2004-01-19	Compounds
AU2003221098A1 (en)	2003-10-08	Oligofluorenylene compounds
AU2003285288A1 (en)	2004-05-04	Composition
AU2003301654A1 (en)	2004-05-13	Stabilized composition
AU2003261725A1 (en)	2004-04-30	Phosphazene composition
AU2002950744A0 (en)	2002-09-12	Composition
AU2003235708A1 (en)	2003-07-30	Polytartrate composition
AU2003226487A1 (en)	2003-09-22	Formulation
AU2003269904A1 (en)	2004-01-23	Antigen-polymer compositions
AU2003282722A1 (en)	2004-04-23	Therapeutic compositions
AU2003293621A1 (en)	2004-05-13	Liposome-forming compositions
AU2003216859A1 (en)	2003-10-08	Amidoacetonitrile compounds
AU2003207307A1 (en)	2003-09-04	Roadbed stabilization
GB0218194D0 (en)	2002-09-11	Solid formulations
AU2003212724A1 (en)	2003-09-29	Composition comprising phosphate
AUPS121202A0 (en)	2002-04-18	Platform
AU2003255727A1 (en)	2004-02-16	Syringes
AU2003207330A1 (en)	2003-09-04	Reel-transporting platform
AU2003208841A1 (en)	2003-09-04	Gasolinen compositions
AU2003235722A1 (en)	2003-07-30	Polymeric compositions
AU2003240225A1 (en)	2003-11-11	Injectable bisphosphonate formulations
AU2003223922A1 (en)	2003-11-10	Deodorant compositions
AU2003304244A1 (en)	2005-01-13	Epoxy-stabilized polyphosphate compositions
GB0214147D0 (en)	2002-07-31	Formulations

Legal Events

Date	Code	Title	Description
2005-01-27	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
2009-12-24	TH	Corrigenda	Free format text: IN VOL 18, NO 2, PAGE(S) 494 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME CHIESI FARMACEUTICI S.P.A., APPLICATION NO. 2003240225, UNDER INID (43) CORRECT THE PUBLICATION DATE TO READ 24.11.2003